EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, NanoVibronix's Enterprise Value is $-1.13 Mil.
NanoVibronix's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-3.55 Mil. Therefore, NanoVibronix's EV-to-EBIT for today is 0.32.
The historical rank and industry rank for NanoVibronix's EV-to-EBIT or its related term are showing as below:
NAOV'
s EV-to-EBIT Range Over the Past 10 Years
Min: -17.43 Med: -3.84 Max: 0.54
Current: 0.32
During the past 13 years, the highest EV-to-EBIT of NanoVibronix was 0.54. The lowest was -17.43. And the median was -3.84.
NAOV's EV-to-EBIT is ranked better than 96.14% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 19.7
vs NAOV: 0.32
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. NanoVibronix's Enterprise Value for the quarter that ended in Dec. 2023 was $-0.92 Mil.
NanoVibronix's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-3.55 Mil. NanoVibronix's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 383.57%.
NanoVibronix EV-to-EBIT Historical Data
The historical data trend for NanoVibronix's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of NanoVibronix's EV-to-EBIT
For the Medical Devices subindustry, NanoVibronix's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NanoVibronix's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, NanoVibronix's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where NanoVibronix's EV-to-EBIT falls into.
NanoVibronix EV-to-EBIT Calculation
NanoVibronix's EV-to-EBIT for today is calculated as:
NanoVibronix's current Enterprise Value is $-1.13 Mil.
NanoVibronix's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.55 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NanoVibronix (NAS:NAOV) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
NanoVibronix's Enterprise Value for the quarter that ended in Dec. 2023 was $-0.92 Mil.
NanoVibronix's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.55 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NanoVibronix EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of NanoVibronix's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NAOV has been successfully added to your 